Principal Financial Group’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-13,084
| Closed | -$236K | – | 2288 |
|
|
2024
Q2 | $236K | Sell |
13,084
-3,681
| -22% | -$66.3K | ﹤0.01% | 2112 |
|
|
2024
Q1 | $306K | Buy |
16,765
+365
| +2% | +$6.66K | ﹤0.01% | 2084 |
|
|
2023
Q4 | $179K | Sell |
16,400
-1,161
| -7% | -$12.7K | ﹤0.01% | 2187 |
|
|
2023
Q3 | $101K | Buy |
17,561
+1,479
| +9% | +$8.48K | ﹤0.01% | 2281 |
|
|
2023
Q2 | $125K | Buy |
16,082
+3,904
| +32% | +$30.3K | ﹤0.01% | 2256 |
|
|
2023
Q1 | $81.2K | Buy |
12,178
+1,230
| +11% | +$8.2K | ﹤0.01% | 2327 |
|
|
2022
Q4 | $97.9K | Buy |
+10,948
| New | +$97.9K | ﹤0.01% | 2297 |
|